Fondazione G. Monasterio CNR-Regione Toscana Pisa-Massa, Italy
Fondazione G. Monasterio CNR-Regione Toscana Pisa-Massa, Italy.
Eur J Prev Cardiol. 2016 Mar;23(4):366-76. doi: 10.1177/2047487315569675. Epub 2015 Feb 2.
Arterial hypertension is a main determinant of arterial remodelling and atherosclerosis. Coronary artery calcium score and carotid intima-media thickness are recognized indices of vascular remodelling. Established biohumoral markers for the diagnosis of atherosclerosis are still lacking in asymptomatic subjects with hypertension.
We aimed to test the association of plasma N-terminal pro B-type natriuretic peptide concentrations with either coronary artery calcium score or carotid intima-media thickness in asymptomatic hypertensive subjects.
We conducted a case-control study on 436 hypertensi.ve and 436 age/sex-matched normotensive subjects from the population of the Montignoso HEart and Lung Project, a community-based study of asymptomatic general population ≥45 years. Subjects underwent N-terminal pro B-type natriuretic peptide measurement, echocardiography and evaluation of coronary artery calcium score and carotid intima-media thickness.
Hypertensive subjects had higher median coronary artery calcium score (60 (interquartile range, 30-112) vs. 15 (interquartile range 3-70) Agatson units, p = 0.007), carotid intima-media thickness (8.6 (interquartile range 7.5-9.1) vs. 7.9 (7.1-8.4) µm, p < 0.001) and indexed left ventricular mass (101 (interquartile range 82-126) vs. 87 (63-91) mg/m2, p = 0.03) than controls, with no differences in left ventricular ejection fraction, diameters, E/E', left atrial area. N-terminal pro B-type natriuretic peptide concentrations were higher in hypertensive subjects with either coronary artery calcium score (p = 0.008) or carotid intima-media thickness >75th (p < 0.006) percentile and highest in combined coronary artery calcium score/carotid intima-media thickness >75th percentile (p = 0.021). In multivariable analysis, N-terminal pro B-type natriuretic peptide independently predicted either coronary artery calcium score or carotid intima-media thickness >75th percentile, but only in hypertensive subjects (odds ratio = 1.87, 95% confidence interval 1.30-2.74, p = 0.001 and odds ratio = 1.99, 95% confidence interval 1.43-2.76, p = 0.001).
In asymptomatic subjects with hypertension, N-terminal pro B-type natriuretic peptide is a marker of hypertension-mediated preclinical vascular disease.
动脉高血压是动脉重塑和动脉粥样硬化的主要决定因素。冠状动脉钙评分和颈动脉内膜中层厚度是公认的血管重塑指标。在无症状高血压患者中,用于诊断动脉粥样硬化的既定生物体液标志物仍然缺乏。
我们旨在测试无症状高血压患者的血浆 N 末端脑钠肽前体浓度与冠状动脉钙评分或颈动脉内膜中层厚度之间的相关性。
我们对来自蒙蒂尼格罗心脏和肺项目人群的 436 例高血压患者和 436 例年龄/性别匹配的正常血压患者进行了病例对照研究,这是一项针对无症状一般人群(≥45 岁)的社区基础研究。患者接受了 N 末端脑钠肽前体测量、超声心动图以及冠状动脉钙评分和颈动脉内膜中层厚度的评估。
高血压患者的中位数冠状动脉钙评分较高(60(四分位距,30-112)vs. 15(四分位距 3-70)Agatson 单位,p=0.007),颈动脉内膜中层厚度较高(8.6(四分位距 7.5-9.1)vs. 7.9(7.1-8.4)µm,p<0.001)和左心室质量指数较高(101(四分位距 82-126)vs. 87(63-91)mg/m2,p=0.03),而对照组左心室射血分数、直径、E/E'、左心房面积无差异。N 末端脑钠肽前体浓度在冠状动脉钙评分(p=0.008)或颈动脉内膜中层厚度>75 百分位(p<0.006)的高血压患者中较高,在冠状动脉钙评分/颈动脉内膜中层厚度>75 百分位的患者中最高(p=0.021)。在多变量分析中,N 末端脑钠肽前体独立预测冠状动脉钙评分或颈动脉内膜中层厚度>75 百分位,仅在高血压患者中(比值比 1.87,95%置信区间 1.30-2.74,p=0.001 和比值比 1.99,95%置信区间 1.43-2.76,p=0.001)。
在无症状高血压患者中,N 末端脑钠肽前体是高血压介导的临床前血管疾病的标志物。